Search Contract Forecasts

New drugs regulatory modernization transition project support

Type: Forecast


DER/OND Safety Staff directly support the following strategic objectives: scientific leadership, integrated assessment, knowledge management, and benefit-risk monitoring. The Postmarket Safety workstream of the New Drugs Regulatory Program developed the Pharmacovigilance (PV) Framework to support efficient and effective safety review in the 21st Century. The Framework includes several initiatives, such as Drugs Safety Teams, Pharmacovigilance Strategy, Integrated Safety Assessment, and Essentials of Drug Safety Curriculum, and refined operating model, that have been initiated but are in need of evaluation and refinement.
Est. Value
Min: $1,500,000
Max: $3,000,000
Est. Award Date
Source Est. Solicitation Date
Set Aside
Full and Open
Forecast Source
Food and Drug Administration is forecasted to issue a procurement for New drugs regulatory modernization transition project support around 7/1/24 worth up to $3,000,000.


Source Level 1 Agency
Health and Human Services
Source Level 2 Agency
Food and Drug Administration


Point of Contact
Nikisha Reid   Profile
Point of Contact Email

Potential Bidders and Partners

Similar Active Opportunities

Additional Detail

Date Published